Restrictionsapply
Planets Sun
copayimage Restrictionsapply Save now
Skip Navigation LinksHome > Diabetes and Insulin > Other Delivery Systems

Other Delivery Systems for NovoLog® Insulin

In addition to the NovoLog® FlexPen® (insulin aspart [rDNA origin] injection) and NovoLog® in a pump, there are several other insulin delivery devices. Many are discreet and ready to use in just a few steps.

The Latest Novo Nordisk Reusable Insulin Pen:
NovoPen Echo®

novopen

NovoPen Echo® is the first and only insulin pen with both half-unit dosing and a memory function, and you can pick from a variety of fun skin designs.

Learn more

NovoPen® Junior

  • The precision of half-unit dosing increments
  • For use with NovoLog® 3-mL (300-unit) PenFill® cartridges and NovoFine® disposable needles*

NovoPen Echo® is replacing NovoPen® Junior, which—like NovoPen® 3 and PenMate®—will no longer be available at the pharmacy. However, you can continue to use your NovoPen® Junior, NovoPen® 3, and PenMate®. If you have any questions about the discontinuation of these products, please call 1-800-727-6500. Ask your doctor about NovoPen Echo® and how it can help you (or your loved one) reach your diabetes goals.

NovoFine® needles fit all major insulin devices

The NovoFine® 32G Tip (6 mm) needle is the thinnest needle from Novo Nordisk available in the United States. It is as thin as two hairs.

The majority of people studied using the NovoFine® 32G Tip needle experienced little or no pain.†

Needles are sold separately and may require a prescription in some states.

Vial and syringe

NovoLog® is available in a 10 mL vial, 100 units/mL (U-100) of NovoLog®.

* PenFill® cartridges sold separately.
Multicenter, randomized, open-label, 2-period, crossover trial in insulin-treated patients with diabetes (type 1 or type 2). Patients were randomized to self administer insulin injections with one needle type followed by the alternative, each for 7 to 14 days. The 2 needle types used were NovoFine® 32-gauge tip x 6 mm and NovoFine® 30-gauge tip x 8 mm.


Indications and Usage

What is NovoLog® (insulin aspart [rDNA origin] injection)?

  • NovoLog® is a man-made insulin used to control high blood sugar in adults and children with diabetes mellitus.

Important Safety Information

Who should not take NovoLog®?

Do not take NovoLog® if:

  • your blood sugar is too low (hypoglycemia) or you are allergic to any of its ingredients.

Before taking NovoLog®, tell your health care provider about all your medical conditions including, if you are:

  • pregnant, plan to become pregnant, or are breastfeeding.
  • taking new prescription or over-the-counter medicines, including supplements.

Talk to your health care provider about how to manage low blood sugar.

How should I take NovoLog®?

  • Read the Instructions for Use and take exactly as directed.
  • NovoLog® is fast-acting. Eat a meal within 5 to 10 minutes after taking it.
  • Know the type and strength of your insulin. Do not change your insulin type unless your health care provider tells you to.
  • Check your blood sugar levels. Ask your health care provider what your blood sugar levels should be and when you should check them.
  • Do not share needles, insulin pens, or syringes. You may give or get an infection from another person.

What should I avoid while taking NovoLog®?

  • Do not drive or operate heavy machinery, until you know how NovoLog® affects you.
  • Do not drink alcohol or use medicines that contain alcohol.

What are the possible side effects of NovoLog®?

Serious side effects can lead to death, including:

Low blood sugar. Some signs and symptoms include:

  • anxiety, irritability, mood changes, dizziness, sweating, confusion, and headache.

Your insulin dose may need to change because of:

  • weight gain or loss, increased stress, illness, or change in diet or level of physical activity.

Other common side effects may include:

  • low potassium in your blood, injection site reactions, itching, rash, serious whole body allergic reactions, skin thickening or pits at the injection site, weight gain, and swelling of your hands and feet.

Get emergency medical help if you have:

  • trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, or confusion.

For more information, please click here for complete NovoLog® Prescribing Information.

NovoLog® is a prescription medicine.

Talk to your doctor about the importance of diet and exercise in your treatment plan.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

PPA Logo Rev
If you need assistance with prescription drug costs, help may be available. Visit pparx.org or call 1-888-4PPA-NOW.

Selected Important Safety Information

Who should not take NovoLog®?

Do not take NovoLog® if:

  • your blood sugar is too low (hypoglycemia) or you are allergic to any of its ingredients.

How should I take NovoLog®?

  • Read the Instructions for Use and take exactly as directed.
  • NovoLog® is fast-acting. Eat a meal within 5 to 10 minutes after taking it.
  • Know the type and strength of your insulin. Do not change your insulin type unless your health care provider tells you to.
  • Check your blood sugar levels. Ask your health care provider what your blood sugar levels should be and when you should check them.
  • Do not share needles, insulin pens, or syringes. You may give or get an infection from another person.

Please click here for additional Important Safety Information

Email to a Friend:

email icon

To(;):

From:

Message: